U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Gadoterate Meglumine Injection
Status: Discontinuation
»Therapeutic Categories: Medical Imaging

Expand all

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (New 06/30/2026)

Company Contact Information:
Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300

Presentation Posting Date Related Information
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) 05/21/2026 Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) 05/21/2026 Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) 05/21/2026 Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) 05/21/2026 Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) 06/30/2026 Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) 06/30/2026 Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) 06/30/2026 Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) 06/30/2026 Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Back to Top